Locations:
Search IconSearch

Tag: immunoglobulin light-chain amyloidosis

amyloid_650x450
November 17, 2021/Cancer/Research

Adding Daratumumab to Treatment Regimen May Improve Outcomes in Patients With Immunoglobulin Light-Chain Amyloidosis

Study associates human CD38-targeting antibody with fewer complications

BackPage 1 of 1Next

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Ad